FP
AVNS

Factorial Partners’s Avanos Medical AVNS Stock Holding History

Factorial Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,400
Closed -$730K – 93
2021
Q3 		$730K Buy
+23,400
New +$794K 0.5% 66
2018
Q1 		– Sell
-20,800
Closed -$961K – 102
2017
Q4 		$961K Buy
+20,800
New +$956K 0.89% 40

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Factorial Partners's AVNS Position: Q4 2021 in Review

Factorial Partners sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 23,400 shares — an estimated $730K sold.

Factorial Partners first reported a position in AVNS in Q4 2017 and held it in 2 quarters. The position peaked at $961K in Q4 2017. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

  • Factorial Partners reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
  • Factorial Partners sold 23,400 Avanos Medical shares in Q4 2021, an estimated $730K.
  • Factorial Partners first reported a position in Avanos Medical in Q4 2017 and held it in 2 quarters.
  • Factorial Partners's Avanos Medical position peaked at $961K in Q4 2017.
  • 297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Factorial Partners's 13F filing for Q4 2021, filed 9 Feb 2022.